Form D · Biotechnology
DELTAGEN INC
San Mateo, CA · CIK 0001034072
Offering snapshot reported Jul 11, 2011 · SEC filing
- Reported sold
- $18.8K Indefinite offering
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 11, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 11, 2011 | Initial | $18,750 | No comparison | 2 | SEC filing |
| Dec 22, 2009 | Initial | $1,523,041 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-162611
Source: Form D, filed Jul 11, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Constantine Anagnostopoulos | Director |
| Robert J. Driscoll | Director, Executive |
| Marty Hernon | Director |
| Paula Z. Mac Donald | Director |
| David J. Mc Lachlan | Director |
| Thomas Penn | Director |
| Daniel Ratto | Executive |
| William Scott | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1900 S. Norfolk Street Suite 105
San Mateo, CA, 94403
San Mateo, CA, 94403